Ignite Creation Date:
2025-12-26 @ 10:43 PM
Ignite Modification Date:
2025-12-26 @ 10:44 PM
Study NCT ID:
NCT05014412
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-10-15
First Post:
2021-08-03
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study to Learn About the Study Medicine (Elranatamab) in Participants With Multiple Myeloma That Has Come Back After Responding to Treatment or Has Not Responded to Treatment
Sponsor:
Pfizer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-10-07
Start Date Type:
ACTUAL
Primary Completion Date:
2023-06-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-10-30
Completion Date Type:
ESTIMATED
First Submit Date:
2021-08-03
First Submit QC Date:
None
Study First Post Date:
2021-08-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-06-11
Results First Submit QC Date:
None
Results First Post Date:
2024-07-30
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-06
Last Update Post Date:
2025-10-15
Last Update Post Date Type:
ESTIMATED